Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol
| Autor: | G. N. Woodruff, H. J. Little, J. Wilson |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Pharmacology
medicine.medical_specialty Ethanol Liquid diet business.industry Ratón Antagonist Medicine (miscellaneous) Biological activity Dose schedule Psychiatry and Mental health chemistry.chemical_compound Endocrinology chemistry Mechanism of action Internal medicine Toxicity Medicine medicine.symptom business |
| Zdroj: | Addiction biology. 4(1) |
| ISSN: | 1355-6215 |
| Popis: | The effects of chronic administration of a CCK(B) antagonist, CAM1028, were examined on the development of tolerance to ethanol and the appearance of withdrawal signs. Ethanol was given chronically by liquid diet, and none of the dose schedules of CAM1028 affected the amount of ethanol taken in during the chronic treatment. Brain ethanol concentrations were not altered by the administration of CAM1028.The ataxic effects of ethanol were tested on a rotorod, 3 hours after cessation of the ethanol administration, and the last injections of CAM1028 were given 8 hours before withdrawal from the ethanol treatment. When administered at 0.03, 0.1 or 0.3 mg/kg, CAM1028 decreased the extent of tolerance development. Higher doses, 1 and 3 mg/kg, did not alter the tolerance development. Chronic administration of CAM1028 had a small effect in protecting against the effects of ethanol withdrawal that, in contrast to the effects on the tolerance, was seen only at the highest dose, 10 mg/kg, of CAM1028. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text